See today's BioWorld MedTech
To read the full story, subscribe or sign in.

FDA clears Artrya’s AI-based coronary anatomy software

April 3, 2025
By Tamra Sami
The U.S. FDA cleared Artrya Ltd.’s Salix Coronary Anatomy software that analyzes coronary computed tomography angiogram scans via AI to better diagnose coronary artery disease.
BioWorld MedTech Regulatory Artificial intelligence Cardiovascular Digital health SAMD U.S. FDA